However, the cost of research and development of natural health products is often impossibly steep as the products must be rigorously tested and proven before they can be placed on store shelves.
With this challenge ahead of them, the Alberta “phyto-pharmaceutical” biotech company, SinoVeda, turned to Mitacs-Accelerate to assist in the advanced testing of its latest natural calcium supplement which is currently undergoing clinical trials.
The company is developing a novel cancer vaccine based on a specific antigen and needed the research expertise to help them understand, at a molecular level, how that antigen is expressed in different types of cancer. They turned to Dalhousie postdoctoral fellow Olga Hrytsenko for insight. Olga’s 17 years of molecular biology experience is the “perfect fit” for the project says Marianne Stanford, Director of Research, at Immunovaccine.
Acculogic, an Ontario-based robotics testing company, saw the potential to advance its theoretical base originally through a Mitacs-Accelerate internship in collaboration with Mario Morfin, a mathematics post-doctoral fellow from York University’s School of Information Technology. When the algorithms for the new optimization process were completed, the company was faced with the challenge of continuing to build upon the advancements that Mario had developed. The company turned to Mitacs Enterprise to provide the necessary funding to be able to maintain their relationship Mario while afford
Since the introduction of mass-production in the automobile industry, efficiency and innovation have been of upmost importance for companies wishing to be on the cutting-edge in this highly competitive business. Aurora, Ontario-based automotive parts supplier Van-Rob Kirchhoff Automotive has found their competitive advantage in the Mitacs-Accelerate program.
For Cyborg Trading Systems (CTS) – a financial technology services company that serves an international network of banks, brokers and professional traders – keeping ahead of competition is absolutely essential. Battling huge enterprises like Thomson Reuters, Bloomberg and Goldman Sachs would seem an almost impossible task for a Canadian SME. With the cost of infrastructure, technology and global employees rising by the second, Lukez is always looking for any and all opportunities to innovate.
Virtual Marine Technology (VMT) is an SME that develops simulators for survival craft, fast response craft and high speed electronic navigation training. Its goal is to improve the safety of personnel at sea by allowing trainees to practice in high risk emergency situations using a safe and effective simulation. As a spin-off company from Memorial University of Newfoundland, VMT is grounded in research and constantly seeking ways to innovate. VMT currently employs 24 full time staff and is part of a growing simulation community in Newfoundland and Labrador.
As a PhD student in Western University's department of Physiology and Pharmacology, Gurjeev’s research focuses on uncovering molecular mechanisms that predispose low birth weight babies to increased risk of developing cardiovascular diseases in adult life.
The research led to a 78% reduction in CT image noise which facilitates a corresponding decrease in the patient radiation exposure required for high quality CT images, saving patients from the potentially harmful effects of X-ray dose radiation. Below is an exclusive interview with Mr. Hashemi, who won the Mitacs Award for Novelty in Application, as presented by the Honourable Gail Shea, Minister of National Revenue at the 2nd Annual Mitacs Awards Reception, held November 28th in Ottawa.
Because of this research, BC Children’s Hospital can how examine all new cases of pediatric brain tumors throughout the entirety of Western Canada with precision and accuracy – thus reducing the (often excessive) intensity of treatment for children with cancer while still effectively treating the disease. Below is an exclusive interview with Ms.
The research led to the completion of a motorized incubator device that now enables researchers to observe live cells for days at a time as they are stretched under the microscope. His work may help to cure a devastating skin blistering disease called epidermolysis bullosa simplex. Below is an exclusive interview with Mr.